Relmada Therapeutics Inc
(NAS:RLMD)
$
4.335
-0.19 (-4.2%)
Market Cap: 462.41 Mil
Enterprise Value: 244.15 Mil
PE Ratio: 0
PB Ratio: 2.23
GF Score: 29/100 Recent Filings
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Financials
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Ownership
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Material News Releases
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Proxy
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Others
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||